Cardinal Health (CAH) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- —
- Estimate
- $2.42
- Surprise
- —
- Score today
- 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Coverage in the report window
- TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280 — benzinga, 2026-08-13
- JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260 — benzinga, 2026-08-13
- Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275 — benzinga, 2026-08-13
Where TrendMatrix's rating stands now
TrendMatrix currently rates CAH Sell at 5.7/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate. Next scheduled report: 2026-11-05.
What argues against it
- Quality below floor (3.6 < 4.0)
- Reward/Risk 0.6:1 at current price — below 1.5:1 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $233.44
- Price target
- $243.30
- Stop
- $222.00
- Upside to target
- +4.2%
- Reward-to-risk
- 0.6:1
The stock trades at 32.3× trailing but 16.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
CAH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Distribution
- Market cap
- $54.06B
- P/E (fwd)
- 16.6
- P/E (ttm)
- 32.3
- 52-week range
- $151.87–$258.30
- Off 52-week high
- 9.6%
- RSI (14)
- 52
- Volume vs avg
- 0.61×
- Score today
- 5.7/10